BRPI0606178A2 - derivados de 3-aril-1,2-benzisoxazol e sua utilização como medicamentos contra o cáncer - Google Patents
derivados de 3-aril-1,2-benzisoxazol e sua utilização como medicamentos contra o cáncerInfo
- Publication number
- BRPI0606178A2 BRPI0606178A2 BRPI0606178-8A BRPI0606178A BRPI0606178A2 BR PI0606178 A2 BRPI0606178 A2 BR PI0606178A2 BR PI0606178 A BRPI0606178 A BR PI0606178A BR PI0606178 A2 BRPI0606178 A2 BR PI0606178A2
- Authority
- BR
- Brazil
- Prior art keywords
- aryl
- nitro
- halogen
- notably
- represent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
DERIVADOS DE 3-ARIL-1,2-BENZISOXAZOL E SUA UTILIZAçãO COMO MEDICAMENTOS CONTRA O CáNCER. A presente invenção refere-se aos novos compostos de fórmula (1): na qual A1 e A2 representam CH ou N; X representa X representa CRa ou N; Y representa CRb ou N; R~ 1~, R~ 2~, R~ 3~ e R~ 4~ idênticos ou diferentes representam notadamente hidrogênio, halogênio, dano, nitro, trifluorometila, OR~ 5~, SR~ 5~, NR~ 5~R~ 6~, C(O)R~ 5~, C(O)0R~ 5~, C(O)NR~ 5~R~ 6~, S(O)~ 2~R~ 5~, S(O)NR~ 5~R~ 6~, S(O)~ 2~NR~ 5~R~ 6~, NR~ 6~C(O)R~ 5~, NR~ 6~C (O)0R~ 5~, alquilas, alquenilas, antas, heteroarilas, aralquilas ou heteroaralquiIas, todos eventualmente substituidos; Ra representa notadamente halogênio, hidroxila, alcóxi, nitro; Rb representa hidrogênio, halogênio, dano, nitro, trifluorometila, -W-(C~ 1~ -C~ 3~aIquil)m-R~ 5~; R~ 5~ e R~ 6~ representam notadamente alquila, aralquila ou heteroaralquilas, eventualmente substituidos; esses compostos estando sob todas as formas isómeras e os sais, a título de medicamentos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0501801A FR2882361A1 (fr) | 2005-02-22 | 2005-02-22 | Nouveaux derives de 3-aryl-1,2-benzisoxazole, compositions les contenant et leur utilisation |
| PCT/FR2006/000375 WO2006090052A1 (fr) | 2005-02-22 | 2006-02-20 | Nouveaux derives de 3-aryl-1 ,2-benzisoxazole, compositions les contenant et leur utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0606178A2 true BRPI0606178A2 (pt) | 2009-06-02 |
Family
ID=35058405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0606178-8A BRPI0606178A2 (pt) | 2005-02-22 | 2006-02-20 | derivados de 3-aril-1,2-benzisoxazol e sua utilização como medicamentos contra o cáncer |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20080070960A1 (pt) |
| EP (1) | EP1861381A1 (pt) |
| JP (1) | JP2008531493A (pt) |
| KR (1) | KR20070110102A (pt) |
| CN (1) | CN101146780A (pt) |
| AR (1) | AR053684A1 (pt) |
| AU (1) | AU2006217799A1 (pt) |
| BR (1) | BRPI0606178A2 (pt) |
| CA (1) | CA2597781A1 (pt) |
| EA (1) | EA200701798A1 (pt) |
| FR (1) | FR2882361A1 (pt) |
| IL (1) | IL185166A0 (pt) |
| MA (1) | MA29265B1 (pt) |
| MX (1) | MX2007010278A (pt) |
| NO (1) | NO20074631L (pt) |
| TW (1) | TW200640884A (pt) |
| UY (1) | UY29390A1 (pt) |
| WO (1) | WO2006090052A1 (pt) |
| ZA (1) | ZA200707080B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2907453B1 (fr) * | 2006-10-24 | 2008-12-26 | Sanofi Aventis Sa | Nouveaux derives du fluorene,compositions les contenant et utilisation |
| AR077405A1 (es) | 2009-07-10 | 2011-08-24 | Sanofi Aventis | Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer |
| FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
| LT2934145T (lt) * | 2012-12-19 | 2018-02-26 | Celgene Quanticel Research, Inc. | Histono demetilazės inhibitoriai |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6884814B2 (en) * | 2001-12-13 | 2005-04-26 | Wyeth | Phenyl benzisoxazoles as estrogenic agents |
| CA2515726C (en) * | 2003-02-11 | 2012-07-10 | Vernalis (Cambridge) Limited | Isoxazole compounds |
| CN100567242C (zh) * | 2003-06-27 | 2009-12-09 | 协和发酵麒麟株式会社 | Hsp90家族蛋白质阻断剂 |
| CA2536089A1 (en) * | 2003-08-20 | 2005-03-03 | Eli Lilly And Company | Ppar modulators |
-
2005
- 2005-02-22 FR FR0501801A patent/FR2882361A1/fr active Pending
-
2006
- 2006-02-20 EP EP06709343A patent/EP1861381A1/fr not_active Withdrawn
- 2006-02-20 MX MX2007010278A patent/MX2007010278A/es not_active Application Discontinuation
- 2006-02-20 AR ARP060100604A patent/AR053684A1/es unknown
- 2006-02-20 WO PCT/FR2006/000375 patent/WO2006090052A1/fr active Application Filing
- 2006-02-20 BR BRPI0606178-8A patent/BRPI0606178A2/pt not_active IP Right Cessation
- 2006-02-20 AU AU2006217799A patent/AU2006217799A1/en not_active Abandoned
- 2006-02-20 CN CNA2006800095240A patent/CN101146780A/zh active Pending
- 2006-02-20 JP JP2007555668A patent/JP2008531493A/ja active Pending
- 2006-02-20 ZA ZA200707080A patent/ZA200707080B/xx unknown
- 2006-02-20 EA EA200701798A patent/EA200701798A1/ru unknown
- 2006-02-20 KR KR1020077021865A patent/KR20070110102A/ko not_active Application Discontinuation
- 2006-02-20 CA CA002597781A patent/CA2597781A1/fr not_active Abandoned
- 2006-02-21 TW TW095105684A patent/TW200640884A/zh unknown
- 2006-02-22 UY UY29390A patent/UY29390A1/es unknown
-
2007
- 2007-08-09 IL IL185166A patent/IL185166A0/en unknown
- 2007-08-20 US US11/841,128 patent/US20080070960A1/en not_active Abandoned
- 2007-08-23 MA MA30161A patent/MA29265B1/fr unknown
- 2007-09-11 NO NO20074631A patent/NO20074631L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2882361A1 (fr) | 2006-08-25 |
| UY29390A1 (es) | 2006-10-02 |
| US20080070960A1 (en) | 2008-03-20 |
| MA29265B1 (fr) | 2008-02-01 |
| ZA200707080B (en) | 2008-11-26 |
| AR053684A1 (es) | 2007-05-16 |
| IL185166A0 (en) | 2007-12-03 |
| KR20070110102A (ko) | 2007-11-15 |
| WO2006090052A1 (fr) | 2006-08-31 |
| AU2006217799A1 (en) | 2006-08-31 |
| CN101146780A (zh) | 2008-03-19 |
| TW200640884A (en) | 2006-12-01 |
| CA2597781A1 (fr) | 2006-08-31 |
| MX2007010278A (es) | 2007-11-07 |
| JP2008531493A (ja) | 2008-08-14 |
| EA200701798A1 (ru) | 2008-02-28 |
| EP1861381A1 (fr) | 2007-12-05 |
| NO20074631L (no) | 2007-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP099044A (es) | Compuestos de pirimido fusionados | |
| BRPI0516841A (pt) | derivados bis-azaindóis, o respectivo preparado e a respectiva utilização farmacêutica como inibidores de quinases | |
| BRPI0512677A2 (pt) | derivados de quinazolina | |
| SV2009002865A (es) | Uso de oxazolidinonas para el tratamiento y profilaxis de microangiopatias | |
| UA98116C2 (ru) | Изоксазолины, композиция, их применение, способы получения и промежуточные соединения | |
| AR067058A1 (es) | Oxazolidinonas sustituidas y su uso para preparar medicamentos | |
| ATE471313T1 (de) | 3,5-di(aryl - oder heteroaryl) isoxazole und 1,2, 4-oxadiazole als s1p1-rezeptoragonisten, das immunsystem unterdrückende und entzündungshemmende mittel | |
| BR0308653A (pt) | Cristais de derivado de benzeno de glicopiranosiloxibenzila | |
| DE602005023343D1 (de) | Pyrimidinderivate als gpcr-agonisten | |
| EA201300200A1 (ru) | N-((6-аминопиридин-3-ил)метил)гетероарилкарбоксамиды в качестве ингибиторов калликреина в плазме | |
| DOP2010000165A (es) | 4-(4-ciano-2-tioaril) dihidropirimidinonas y su uso como inhibidores de la elastasa neutrofila humana | |
| CR10157A (es) | Compuestos químicos | |
| BRPI0508182A (pt) | benzotiazóis e sua utilização como medicamentos | |
| BRPI0515081B8 (pt) | composto, processo para a preparação de um sal de guanidino trifluormetilaroil amida, processo para a preparação de um fenil amino pirido pirimidina, composições farmacêuticas e processos para preparar (3,5-bis trifluormetil)-n-[4-metil-3-(4-piridin-3-il-pirimidin-2-ilamino)-fenil]-benzamida | |
| UY29393A1 (es) | Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones. | |
| UY30610A1 (es) | Moduladores de mglur5 | |
| MY175373A (en) | Crystal form of phenylamino pyrimidine derivatives | |
| UY30404A1 (es) | Nuevas formas cristalinas de acido (trans-4-{4-[({5-[(3,4-difluorofenil)amino]-1,3,4-oxadiazol-2-il}carbonil)amino]fenil}cilohexil)acético, composiciones y aplicaciones | |
| BRPI0606178A2 (pt) | derivados de 3-aril-1,2-benzisoxazol e sua utilização como medicamentos contra o cáncer | |
| SE0400850D0 (sv) | Novel Compounds | |
| NO20084282L (no) | Ny krystallinsk form for (5S)-5-[4-(5-klorpyridin-2-yloksy)piperidin-1-sulfonylmetyl]-5-metylimidazolin-2,4-dion(l) og mellomprodukter derav | |
| BR112012017188A8 (pt) | composto agonista de mglu2, sua composição farmacêutica e seu uso | |
| UY30788A1 (es) | Compuestos quimicos | |
| BRPI0613999B8 (pt) | uso de um composto derivado de quinolina, o referido composto, sua combinação, composição farmacêutica, uso da referida combinação, e produto | |
| GT200700105A (es) | Inhibidor del factor xa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 5A E 6A ANUIDADES. |